JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $549,000 | -44.4% | 12,000 | -45.5% | 0.00% | -60.0% |
| Q3 2017 | $987,000 | -28.1% | 22,000 | -38.4% | 0.01% | -28.6% |
| Q2 2016 | $1,372,000 | -6.2% | 35,692 | -7.0% | 0.01% | 0.0% |
| Q1 2016 | $1,463,000 | -75.4% | 38,397 | -71.6% | 0.01% | -75.9% |
| Q4 2015 | $5,950,000 | -14.9% | 135,310 | -21.3% | 0.03% | -23.7% |
| Q3 2015 | $6,994,000 | +48.8% | 171,887 | +95.1% | 0.04% | +81.0% |
| Q2 2015 | $4,699,000 | -5.1% | 88,112 | +7.9% | 0.02% | -4.5% |
| Q1 2015 | $4,952,000 | +16.1% | 81,628 | -0.1% | 0.02% | +4.8% |
| Q4 2014 | $4,266,000 | – | 81,698 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |